Molecular alterations of the IDH1 gene in AML: a Children's Oncology Group and Southwest Oncology Group study-Reference-Cited by-同舟云学术

Molecular alterations of the IDH1 gene in AML: a Children's Oncology Group and Southwest Oncology Group study

Published:2010-04-08 Issue:5 Volume:24 Page:909-913
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Ho P A,Alonzo T A,Kopecky K J,Miller K L,Kuhn J,Zeng R,Gerbing R B,Raimondi S C,Hirsch B A,Oehler V,Hurwitz C A,Franklin J L,Gamis A S,Petersdorf S H,Anderson J E,Reaman G H,Baker L H,Willman C L,Bernstein I D,Radich J P,Appelbaum F R,Stirewalt D L,Meshinchi S

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu201056.pdf

Reference18 articles.

1. Parsons DW, Jones S, Zhang X, Lin JC, Leary RJ, Angenendt P et al. An integrated genomic analysis of human glioblastoma multiforme. Science 2008; 321: 1807–1812.

2. Balss J, Meyer J, Mueller W, Korshunov A, Hartmann C, von Deimling A . Analysis of the IDH1 codon 132 mutation in brain tumors. Acta Neuropathol 2008; 116: 597–602.

3. Bleeker FE, Lamba S, Leenstra S, Troost D, Hulsebos T, Vandertop WP et al. IDH1 mutations at residue p.R132 (IDH1(R132)) occur frequently in high-grade gliomas but not in other solid tumors. Hum Mutat 2009; 30: 7–11.

4. Yan H, Parsons DW, Jin G, McLendon R, Rasheed BA, Yuan W et al. IDH1 and IDH2 mutations in gliomas. N Engl J Med 2009; 360: 765–773.

5. Hartmann C, Meyer J, Balss J, Capper D, Mueller W, Christians A et al. Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1010 diffuse gliomas. Acta Neuropathol 2009; 118: 469–474.

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cysteine- and glycine-rich protein 1 predicts prognosis and therapy response in patients with acute myeloid leukemia;Clinical and Experimental Medicine;2024-03-28

2. Aberrant HIF1- α and SIX-1 Expression is Associated with Poor Prognosis in Acute Myeloid Leukemia Patients with Isocitrate Dehydrogenase 1 Mutations;Cancer Control;2024-01

3. Epigenetic dysregulation in cancers by isocitrate dehydrogenase 2 (IDH2);Advances in Protein Chemistry and Structural Biology;2024

4. Characteristics and prognostic impact of IDH mutations in AML: a COG, SWOG, and ECOG analysis;Blood Advances;2023-10-02

5. Is the IDH Mutation a Good Target for Chondrosarcoma Treatment?;Current Molecular Biology Reports;2020-01-11